Upcoming joint Sessions & Events
ESOI-ESHIMT-ESUR Session at ECR 2020
ESOI is excited about their joint session together with the European Society for Hybrid, Molecular and Translational Imaging and the European Society of Urogenital Radiology at the European Congress of Radiology (ECR) 2020, the annual meeting of the European Society or Radiology.
Refresher Course | Prostate cancer management: pushing the diagnostic frontier
March 12, 2020 | 14:00 – 15:30
Please visit the ECR congress website for further information and registration.
EACR-ESOI Joint Symposium at EACR 2020
ESOI is delighted to announce their joint symposium with the European Association of Cancer Research (EACR) on occasion of their annual meeting. The EACR Congress 2020 entitled “Innovative Cancer Science – Better Outcomes Through Research” will take place in Turin, Italy, between June 17-20, 2020.
The four day congress will be dedicated to basic, preclinical and translational cancer research across a wide breadth of topics.
EACR-ESOI Joint Symposium: Intra Vital Imaging and Metastasis
June 19, 2020 | 11:15 – 12:50
Please visit the EACR congress website for further information, registration and updates.
Previous joint Sessions & Events
Joint ESOI Session with the Moscow Expert Society MRO
ESOI was excited to take part in the joint sessions with the Moscow Expert Society MRO on occasion of their annual meeting “Oncologic Imaging”.
December 13-14, 2019 | Moscow/RU
Find more details here
Scientific Seminar “Imaging in assessing response to cancer therapy”
ESOI was invited by the Omega Kiev Medical Center to organise a scientific seminar in collaboration with the National Cancer Institute Kiev and the Association of Radiologists on October 12, 2019.
You can view the programme here.
ESOI reaches out to other socities!
ESOI is proud to have established close relations with a number of international non-radiological societies that play crucial roles in the field of oncology. By identifying common grounds for collaboration, ESOI aims to work together with its esteemed partners to extend, strengthen and promote multidisciplinarity in cancer management.
Alongside multidisciplinary collaboration, ESOI strives towards working together with national radiological societies as well as other radiological subspecialty societies with the aim of ensuring and providing high quality education.
Collaboration between ESOI and EACR
ESOI is proud to announce their signed Memorandum of Understanding with the European Association for Cancer Research.
Collaboration between ESOI and ESDO
ESOI is proud to announce their signed Memorandum of Understanding with the European Society of Digestive Oncology.
Collaboration between ESOI and ESSO
ESOI is proud to announce their signed Memorandum of Understanding with the European Society of Surgical Oncology.
Collaboration between ESOI and ESTRO
ESOI is proud to announce their signed Memorandum of Understanding with the European SocieTy for Radiotherapy and Oncology.
Collaboration between ESOI and SOII
ESOI is proud to announce their signed Memorandum of Understanding with the Society of Oncologic Imaging India.
Regina Beets-Tan appointed to Mission Board for Cancer
Professor Regina Beets-Tan, immediate past president of ESOI, named to serve on the mission board for the cancer mission of Horizon Europe, the new research & innovation initiative mandated by the European Commission.
New ESOI President
ESOI welcomes Prof. Dr. Andrea Laghi as the new ESOI President for the period 2019-2021.
1000th ESOI Member
ESOI is proud to announce the membership of its 1000th member. We would like to thank everyone for their support and look forward to even further growth of our community.
ESOI announces ECCO Membership
ESOI is proud to announce their accepted membership application with the European CanCer Organisation.
ECCO represents and serves the interests of over 150 000 professionals in oncology through its 27 Member Societies. It provides a cohesive platform for European Cancer Societies and Organisations with the aim to work together to improve cancer patient outcomes, and to be the unified voice of the European cancer community when addressing common policy issues.